AlayaCare Releases Predictions for Home-Based Care in 2024: Transformative Trends Unveiled  

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TORONTO, ON / ACCESSWIRE / January 10, 2024 / In a comprehensive analysis of the future of home-based care in North America, AlayaCare co-founder and CEO Adrian Schauer shares predictions and trends set to redefine healthcare in 2024.

The 2024 forecast outlines key transformations in home health, home care, and home infusion, shedding light on the evolution of care delivery models and technology integration in the US and Canada.

Embracing the AI Revolution

The cornerstone of Schauer’s predictions lies in the continued proliferation of Artificial Intelligence (AI) and machine learning within the home-based care industry. This technology is set to revolutionize care delivery, introducing innovative solutions that will transform approaches to patient care management.

Schauer highlights the impactful role of AI in areas such as patient risk stratification, predictive analytics, and enhanced collaboration across the care continuum. Notably, the introduction of conversational computing, exemplified by AlayaCare’s own AI chatbot Layla, showcases the potential for AI-driven tools to improve outcomes and bolster clinician capabilities.

Regulatory Frameworks and Value-Based Care

The predictions also underscore the necessity for clearer regulatory frameworks governing AI in healthcare. Anticipating precise guidelines to ensure ethical AI usage and data privacy, Schauer emphasizes the collaboration required between tech companies, health systems, and regulators for cohesive and secure implementation.

Furthermore, Schauer predicts an expansive shift toward the value-based care model. This transformation, already underway in the US, is expected to expand into Canada, emphasizing outcomes over service volume and fostering data connectivity among healthcare providers for seamless care coordination.

Personalized Care and Integrated Models

An imminent shift towards highly personalized care plans, driven by advanced data analytics and a deeper understanding of social determinants of health (SDOH), is highlighted in Schauer’s predictions. This evolution emphasizes the importance of client-centered care and increased involvement of clients and their families in the care process.

Additionally, the Canadian landscape is poised for a remarkable evolution towards integrated care models, promoting collaboration between public and private sectors to deliver holistic care at home.

Amplified Collaboration in Home Infusion Therapy

The forecast also emphasizes the amplified collaboration between infusion nursing agencies and specialty pharmacies. This collaboration is set to streamline the medication supply chain and elevate patient care through innovation and operational efficiency.

As all these trends gather momentum, Schauer envisions a more efficient, personalized, and holistic healthcare system that will redefine the dynamics of home-based care.

For more detailed insights into Schauer’s predictions for home-based care in 2024, read the full report here.

To speak to Schauer or for more information, contact:

AlayaCare Press Contact:
Steph Davidson
steph.davidson@alayacare.com
647-668-6369

About AlayaCare

AlayaCare is an end-to-end software platform for public, private, non-profit, and community home-based care organizations that manages the entire client lifecycle, including needs assessments, care plans, scheduling, visit and route optimization, and visit verification. Founded in 2014 with over 600 employees, AlayaCare combines traditional in-home and virtual care solutions that enable care providers to lower the cost of care and achieve better outcomes for their clients. For more information, visit: AlayaCare.com

SOURCE: AlayaCare

View the original press release on accesswire.com

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

16 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

16 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

16 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

16 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

16 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

16 hours ago